MTOR and nonpapillary renal cell carcinoma: Univariate survival analysis demonstrated that high p-mTOR expression was associated with a shorter CSS in patients with ccRCC (hazard ratio (HR) 2.933, 95% confidence interval (CI) [1.891–4.549], P < 0.001, Table 2).